TL
DXCM icon

Tirschwell & Loewy’s DexCom DXCM Stock Holding History

Tirschwell & Loewy’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$33.6M Sell
1,130,156
-3,860
-0.3% -$136K 4.6% 5
2018
Q4 		$34M Sell
1,134,016
-12,200
-1% -$387K 5.15% 1
2018
Q3 		$41M Sell
1,146,216
-14,600
-1% -$453K 5.12% 3
2018
Q2 		$27.6M Buy
1,160,816
+1,500
+0.1% +$31.8K 3.66% 9
2018
Q1 		$21.5M Buy
1,159,316
+37,136
+3% +$549K 2.96% 14
2017
Q4 		$16.1M Buy
1,122,180
+39,800
+4% +$517K 2.27% 21
2017
Q3 		$13.2M Buy
1,082,380
+11,600
+1% +$205K 2% 24
2017
Q2 		$19.6M Buy
1,070,780
+24,100
+2% +$445K 3.07% 13
2017
Q1 		$22.2M Sell
1,046,680
-2,400
-0.2% -$46.8K 3.59% 7
2016
Q4 		$15.7M Sell
1,049,080
-37,000
-3% -$655K 2.8% 13
2016
Q3 		$23.8M Sell
1,086,080
-420
-0% -$9.35K 3.96% 5
2016
Q2 		$21.5M Sell
1,086,500
-1,040
-0.1% -$17.7K 3.77% 5
2016
Q1 		$18.5M Buy
1,087,540
+44,760
+4% +$748K 3.23% 10
2015
Q4 		$21.4M Buy
1,042,780
+11,000
+1% +$229K 3.76% 7
2015
Q3 		$22.1M Sell
1,031,780
-59,320
-5% -$1.32M 4.17% 4
2015
Q2 		$21.8M Buy
1,091,100
+3,000
+0.3% +$52.7K 3.68% 9
2015
Q1 		$17M Sell
1,088,100
-9,000
-0.8% -$136K 2.83% 13
2014
Q4 		$15.1M Sell
1,097,100
-1,800
-0.2% -$22K 2.44% 17
2014
Q3 		$11M Sell
1,098,900
-13,400
-1% -$137K 1.84% 23
2014
Q2 		$11M Buy
1,112,300
+971,900
+692% +$8.61M 1.79% 23
2014
Q1 		$1.45M Sell
140,400
-800
-0.6% -$8.27K 0.25% 55
2013
Q4 		$1.25M Hold
141,200
– – 0.22% 57
2013
Q3 		$996K Hold
141,200
– – 0.19% 62
2013
Q2 		$792K Buy
+141,200
New +$676K 0.17% 68

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Tirschwell & Loewy's DXCM Position: Q1 2019 in Review

Tirschwell & Loewy reduced its DexCom (DXCM) stake by 0.34% in Q1 2019, selling an estimated $136K and leaving 1,130,156 shares worth $33.6M. The position accounts for 4.6% of the portfolio, ranked #5.

Tirschwell & Loewy first reported a position in DXCM in Q2 2013 and has held it in 24 quarters since. The position peaked at $41M in Q3 2018. 456 funds tracked by Wall St. Rank hold DXCM as of Q1 2019.

  • Tirschwell & Loewy held 1,130,156 shares of DexCom worth $33.6M as of Q1 2019.
  • Tirschwell & Loewy sold 3,860 DexCom shares in Q1 2019, an estimated $136K.
  • DexCom made up 4.6% of Tirschwell & Loewy's portfolio in Q1 2019, its #5 holding.
  • Tirschwell & Loewy first reported a position in DexCom in Q2 2013 and has held it in 24 quarters since.
  • Tirschwell & Loewy's DexCom position peaked at $41M in Q3 2018.
  • 456 funds tracked by Wall St. Rank held DexCom as of Q1 2019.

Based on Tirschwell & Loewy's 13F filing for Q1 2019, filed 3 Apr 2019.